Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Members (as of December 31, 2009) Membership in the Forum includes a diverse Peter Corr, PhD Freda Lewis-Hall, MD range of stakeholders from multiple sectors, Co-Founder and General Partner, Celtic Senior Vice President and Chief Medical including government, the pharmaceutical Therapeutics Management, LLLP Officer, Pfizer, Inc. and biotechnology industries, academic health James H. Doroshow, MD, FACP William D. Matthew, PhD centers, and patient groups. Director, Division of Cancer Treatment and Director of Translational Research, National Diagnosis, National Cancer Institute Institute of Neurological Diseases and Stroke Co-Chairs Paul R. Eisenberg, MD, MPH Mark B. McClellan, MD, PhD Gail H. Cassell, PhD Senior Vice President, Global Regulatory Affairs Director, Engelberg Center for Health Care Vice President, Scientific Affairs and and Safety, Amgen, Inc. Reform, Brookings Institution Distinguished Lilly Research Scholar for Gary L. Filerman, PhD Carol Mimura, PhD Infectious Diseases, Eli Lilly and Company Senior Vice President and Chairman, Health Assistant Vice Chancellor, Intellectual Property Jeffrey M. Drazen, MD Management and Policy Group, Atlas Research & Industry Research Alliances, University of Editor-in-Chief, New England Journal of California, Berkley Garret A. FitzGerald, MD Medicine Professor of Medicine, Professor and Chair of John Orloff, MD Pharmacology, Department of Pharmacology, Senior Vice President, U.S. Medical & Drug Members University of Pennsylvania School of Medicine Regulatory Affairs, Novartis Pharmaceuticals Corporation Barbara Alving, MD, MACP Elaine K. Gallin, PhD Director, National Center for Research Director, Medical Research Programs, Doris Amy P. Patterson, MD Resources Duke Charitable Foundation Acting Director, Office of Science Policy National Institutes of Health Hal Barron, MD Steven K. Galson, MD, MPH Senior Vice President, Development and Chief Rear Admiral (ret.), U.S. Public Health Service Janet Shoemaker Medical Officer, Genentech Director, Office of Public Affairs, American Harry B. Greenberg, MD Society for Microbiology Leslie Z. Benet, PhD Senior Associate Dean for Research, Joseph D. Professor, Department of Biopharmaceutical Grant Professor of Medicine and Microbiology Lana Skirboll, PhD Sciences, School of Pharmacy, University of & Immunology, Stanford University School of Acting Director, Division of Program California, San Francisco Medicine Coordination, Planning, and Strategic Initiatives, National Institutes of Health Ann Bonham, PhD Stephen Groft, PharmD Chief Scientific Officer, Association of Director, Office of Rare Disease Research, Nancy Sung, PhD American Medical Colleges National Institutes of Health Senior Program Officer, Burroughs Wellcome Fund Catherine Bonuccelli, MD Peter Honig, MD, MPH Vice President, External Scientific Affairs, Senior Vice President, Worldwide Regulatory Jorge A. Tavel, MD AstraZeneca Pharmaceuticals Affairs (ret.), Merck Deputy Director, Division of Clinical Research, National Institute of Allergy and Infectious Linda Brady, PhD A. Jacqueline Hunter, PhD Diseases Director, Division of Neuroscience and Basic Senior Vice President, Science Environment Behavioral Science, National Institute of Development, GlaxoSmithKline Joanne Waldstreicher, MD Mental Health Senior Vice President, Johnson & Johnson Michael Katz, MD Pharmaceutical Research & Development Robert Califf, MD Senior Vice President for Research and Global Director, Duke Translational Medicine Institute, Programs, March of Dimes Foundation Janet Woodcock, MD Professor of Medicine, Vice Chancellor for Director, Center for Drug Evaluation and Jack D. Keene, PhD Clinical and Translational Research, Duke Research, U.S. Food and Drug Administration James B. Duke Professor, Duke University University Medical Center Medical Center, Molecular Genetics & Raymond L. Woosley, MD, PhD Scott Campbell, PhD Microbiology Founder and Chief Executive Officer, Critical National Vice President, American Diabetes Path Institute Ronald L. Krall, MD Association Senior Vice President and Chief Medical Officer, GlaxoSmithKline (ret.) 11
Membership Patient Advocacy 8% Foundations and Government Associations 24% 10% Biotech/Other Industry 10% Academic Health Centers Pharma 20% 18% Miscellaneous 10% Sponsors Private Foundations National Institute of Allergy and Infectious Burroughs Wellcome Fund Diseases (National Institutes of Health) Doris Duke Charitable Foundation National Institute of Mental Health March of Dimes Birth Defects Foundation (National Institutes of Health) National Institute of Neurological Disorders Other Nonprofit Organizations and Stroke (National Institutes of Health) American Diabetes Association Office of Rare Disease Research American Society for Microbiology (National Institutes of Health) Association of American Medical Colleges Critical Path Institute Industry Sponsors Amgen, Inc. Government Sponsors AstraZeneca Pharmaceuticals Food and Drug Administration Celtic Therapeutics Management, LLLP National Cancer Institute Eli Lilly and Company (National Institutes of Health) Genentech National Center for Research Resources GlaxoSmithKline (National Institutes of Health) Novartis Pfizer, Inc. 12
Janet Woodcock, FDA; Ronald Farkas, FDA; Arthur Holden, International Seious Adverse Events Consortium; Lon Cardon, Glaxo Smith Kline FORUM STAFF Additional Information Robert B. Giffin For more information about the Forum on Drug Discovery, Director Development, and Translation, please visit our web site at: www.iom.edu/drug. Rebecca A. English Research Associate About the Institute of Medicine Yeonwoo Lebovitz The Institute of Medicine serves as adviser to the nation to improve Program Associate health. Established in 1970 under the charter of the National Acad- Genea S. Vincent emy of Sciences, the Institute of Medicine provides independent, Senior Program Assistant objective, evidence-based advice to policymakers, health profes- sionals, the private sector, and the public. The mission of the Insti- Andrew Pope Director, IOM Board on Health Sciences Policy tute of Medicine embraces the health of people everywhere.
Forum on Drug Discovery, Development, and Translation Institute of Medicine 500 Fifth Street, NW Washington, DC 20001 www.iom.edu/drug
